期刊文献+

螨性过敏性疾病的免疫治疗研究进展 被引量:2

Research progress in the immunotherapy of allergic diseases induced by dust mite
原文传递
导出
摘要 尘螨分布广泛,其蜕皮、尸体,尤其是代谢产物都是强烈致敏原,是引起各类过敏性疾病的重要病因之一,其中最主要的是引起过敏性哮喘。螨性过敏性疾病在全球的发生及其严重程度正日渐受到关注。免疫治疗作为一种针对螨性过敏性疾病的对因治疗,受到人们越来越多的重视。本文对螨性过敏性疾病免疫治疗方法,如特异性免疫治疗(SIT)、DNA-变应原免疫疗法、抗IgE单克隆抗体免疫疗法、抗CD11a单克隆抗体免疫疗法、趋化因子受体拮抗剂免疫疗法和抗FcγRⅠ单克隆抗体免疫疗法等进行了综述。 Dust mites are widespread all over the world,their ecdyses,bodies,especially their metabolic products are all intensity allergens.They are one of the important reasons for causing different kinds of allergic diseases,among which allergic asthma is the most major one.The epidemic and the serious status of allergic diseases caused by house dust mites have been paid more attention day by day.Recently,it was regard immunotherapy as an important etiological treatment for allergic diseases caused by house dust mites.The article reviewed some new strategies about the immunotherapy of the allergic diseases,including SIT,DNA-based immunotherapy,monoclonal anti-IgE antibody immunotherapy,monoclonal anti-CD11a antibody immunotherapy,chemokine receptors antagonist immunotherapy and monoclonal anti-FcγRⅠantibody immunotherapy.
作者 冯萌 程训佳
出处 《中国病原生物学杂志》 CSCD 2009年第12期949-951,共3页 Journal of Pathogen Biology
基金 国家863计划资助项目(No.2007AA02Z472) 国家基础科学人才培养基金项目(No.J0730860)
关键词 尘螨 螨性过敏性疾病 免疫治疗 综述 Dust mite allergic diseases immunotherapy review
  • 相关文献

参考文献13

  • 1Weghofer M,Thomasw WR,Pittner G, et al. Comparison of purified Derrnatophagoides pteronyssinus allergens and extract by two-dimensional immunoblotting and quantitative immunoglobulin E inhibitions[J]. Clin Exp Allergy, 2005,35 : 1384-- 1391.
  • 2From the Global Strategy for Asthma Management and Prevention,Global Initiative for Asthma (GINA) 2006[OL]. Available from.. http..//www, ginasthma, org.
  • 3GINA reports: Global Burden of Asthma[OL]. Available on www. ginasthma, org.
  • 4Alvarez-Cuesta E, Bousquet J, Canonica GW, et al. Standards for practical allergen specific immunotherapy [ J ]. Allergy, 2006, 61 (82Suppl) : 1--20.
  • 5Tighe H, Takabayashi K, Raz E, et al. Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity[J]. J Allergy Clin Immunol,2000,106(1 Pt 1) :124--134.
  • 6Tulic MK,Fiset PO,Christodoulopoulos P.et al. Amb a 1 immu nostimulatory oligodeoxynueleotide conjugate immunotherapy decreases the nasal inflammatory response[J]. J Allergy Clin Immunol,2004,113:235--241.
  • 7Hochhaus G, Brookman L, Fox H, et al. Pharmacodynamics of omalizumab:implications for optimized dosing strategies and clinical efficacy in the treatment of allergic asthma[J]. Curt Med Res Opin, 2003,19 : 491 -- 498.
  • 8Busse W,Corren J, I.anier BQ, et al. Orualizumab, anti-IgE recombinant humanized monoclonal antibody,for the treatment of severe allergic asthma[J]. J Allergy Clin Immunol, 2001,108 : 184-- 190.
  • 9Buhl R, Soler M, Matz J, et al. Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma[J]. Eur Respir J,2002,20:73--78.
  • 10Gauvreau GM,Becker AB,Boulet LP,et al. The effects of an anti-cdll mAb,efalizumab,on allergen-induced airway responses and airway inflammation in subjects with atopic asthma[J]. J Allergy Clin Immunol,2003,112:331-- 338.

同被引文献11

  • 1Dinakar C,Portnoy JM.Allergen immunotherapy in the preven-tion asthma[J].Curt Opin Allergy Clin Immunol,2004,4(2):131-6.
  • 2Inerot S, Heinegard D, Olsson SE, et al. Proteoglycan alterations during developing experimental osteoarthritis in a novel hip joint model. J Orthop Res 1991; 9:658 - 73
  • 3Karin H, Lisbet C, Staffan J, et al. Chondrocyte and chondrosarcoma cell integrins with affinity for collagen type Ⅱ and their response to mechanical stress. Exp Cell Res 1995; 221:496 - 503
  • 4Hus SM, Raine L, Franger H. Use of avidin-biotin-peroxidase complex(ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577 - 80
  • 5Dupuis H, Zerlett G. Beanspruchung des Menschen durch mechanische Schwingungen. Hrsg. Bonn/Berlin: Hauptverband der gewerblichen Berufsgenossenschaften 1984:17 - 60
  • 6Taylor W, Pelmear PL, Pearson JCG. Raynaud's phenomenon of occupational origin. An epidemiological survey. Acta Chir Scand (Suppl) 1976; 465:27 - 32
  • 7Sergl HG. Experimental animal studies on a ''vibration theory'' . Fortschr Kieferorthop 1983; 44 ( 1 ): 28 - 38
  • 8温廷桓.上海粉尘螨变应原及特异性免疫治疗(英文)[J].中国寄生虫学与寄生虫病杂志,2009,27(5):419-425. 被引量:6
  • 9王海宁,陈文魁,李朝品,姜玉新.尘螨Ⅰ类变应原所致过敏性哮喘治疗的研究进展[J].中国病原生物学杂志,2010,5(3):231-234. 被引量:4
  • 10张超,姜玉新,李朝品.螨性哮喘特异性免疫治疗机制研究进展[J].中国病原生物学杂志,2010,5(4):313-316. 被引量:3

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部